JAZZ vs SLDE · P/E 1988, rev $2.28B vs rev $1.16B
Jazz Pharmaceuticals PLC (JAZZ) versus Slide Insurance Holdings, Inc. Common Stock (SLDE) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Slide Insurance Holdings, Inc. Common Stock (SLDE) is a insurance - property & casualty company listed on US.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported SLDE revenue for 2025-12-31 was $1.16B. Net income was $444.0M. Revenue was up 36.5% from 2024-12-31 to 2025-12-31. SLDE currently screens at market cap $0.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. SLDE currently screens at market cap $0.
Not investment advice. Open the JAZZ and SLDE stock pages for the full models.
Not investment advice.